RxPharma AB

Active
559446-2201Limited company (AB)Registered 2023HABO

Key figures

512 815 kr−39,5%
Revenue 2025
−39,5%
Average annual change 2024–2025
0250 k500 k750 k1 m20242025

Key figures

2025

Summary: RxPharma AB

What kind of company is it?

RxPharma AB (org. no. 559446-2201) is a limited company (AB). The company was registered in 2023 and has existed for 3 years. Registered seat: Habo. Industry according to Statistics Sweden: temporary employment agency activities (SNI 78201).

How is the company doing financially?

Net sales in financial year 2025 were 512 815 kr, down 39,5 % on the previous year (847 685 kr). Net profit for 2025 was 130 913 kr (25,5 % of net sales). At the end of financial year 2025, total assets were 198 787 kr and equity 158 548 kr (equity ratio 79,8 %). The annual report for 2025 proposes a dividend of 133 500 kr.

Where does the data come from and how up to date is it?

Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by 2 people. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.

Dividend

from the annual report
2025

Proposed dividend 133 500 kr.

History
2025133 500 kr
2024150 000 kr
Summary of annual reports2024–2025
20242025
Sales revenue847 685512 815
Profit for the reporting year152 635130 913
Retained earnings of previous periods——
Total assets272 301198 787
Total liabilities94 66640 239
Total equity177 635158 548
Employees——
Proposed dividend150 000133 500

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

Similar companies